A Study on Overcoming Post‐TACE Drug Resistance in HCC Based on Controllable Oxygen Release‐Magnetic Hyperthermia Therapy
Advanced Healthcare Materials · 2024-12 · 13 (32)
DOI: 10.1002/adhm.202402253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 25.09.2024. Verfasst von Jin-Xin Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Eng…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hyperthermia, Induced, Liver Neoplasms, Oxygen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangsu Provincial Medical Innovation Center.
Abstract (Originalsprache)
Drug‐eluting bead transcatheter arterial chemoembolization (D‐TACE) is one of the first‐line treatment for intermediate hepatocellular carcinoma (HCC). However, the dual hypoxia microenvironment, due to inherent tumor hypoxia and TACE‐induced hypoxia, triggers drug resistance in HCC. To address this challenge, the study develops multicavitary microspheres capable of encapsulating oxygen and harnessing magnetic hyperthermia to enhance oxygen permeability. The novel multicavitary oxygen‐encapsulated magnetothermal drug‐eluting microspheres (OTD‐Ms) effectively reduce hypoxia‐related proteins (HIF‐1α, VEGF‐A) and drug resistance (P‐gp) both in vitro and in vivo. Moreover, these microspheres demonstrate improved TACE efficacy and enhance survival rates in a rabbit VX‐2 tumor model, suggesting their potential for HCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Engineering, Southeast University, Nanjing, 210009, P. R. China.
- Center of Interventional Radiology and Vascular Surgery, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Department of Radiology, Zhongda Hospit…
- National Innovation Platform for Integration of Medical Engineering Education (NMEE) (Southeast University), Nanjing, 210009, P. R. China.
- Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing, 210009, P. R. China.
- Department of Radiology, Zhongda Hospital, Medical School, Southeast University, 87 Dingjiaqiao Road, Nanjing, 210009, P. R. China.
- Department of Pharmacy, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, P. R. China.
ORCID-Profile: Fei Xiong
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Jiangsu Provincial Medical Innovation Center
- Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
- Nanjing Life Health Science and Technology Project
Zitieren
APA
Huang, J. X., Zhang, W. H., Wu, Y. M., Hu, J. Y., Long, H., Zhu, H. D., Zhang, J. Q., Teng, G. J., & Xiong, F. (2024). A Study on Overcoming Post‐TACE Drug Resistance in HCC Based on Controllable Oxygen Release‐Magnetic Hyperthermia Therapy. Advanced Healthcare Materials, 13(32). https://doi.org/10.1002/adhm.202402253
Vancouver
Huang JX, Zhang WH, Wu YM, Hu JY, Long H, Zhu HD, et al. A Study on Overcoming Post‐TACE Drug Resistance in HCC Based on Controllable Oxygen Release‐Magnetic Hyperthermia Therapy. Advanced Healthcare Materials. 2024;13(32). doi:10.1002/adhm.202402253
BibTeX
@article{Huang2024,
author = {Huang, Jin-Xin and Zhang, Wei-Hua and Wu, Ye-Ming and Hu, Jian-Yu and Long, Huan and Zhu, Hai-Dong and Zhang, Jian-Qiong and Teng, Gao-Jun and Xiong, Fei},
title = {A Study on Overcoming Post‐TACE Drug Resistance in HCC Based on Controllable Oxygen Release‐Magnetic Hyperthermia Therapy},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {32},
doi = {10.1002/adhm.202402253}
}
EUVIMED